NCT02152358View on ClinicalTrials.gov

PTH - Preemptive Treatment for Herpesviridae

PHASE4CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

February 5, 2014

Primary Completion Date

April 21, 2018

Study Completion Date

April 5, 2023

Conditions
Viral Pneumonia
Interventions
DRUG

Aciclovir

Intravenous 15 mg/kg/d during 14 days

DRUG

Ganciclovir

intravenous 10 mg/kg/d for 14 days

DRUG

Placebo

Trial Locations (1)

13015

Assistance Publique - Hôpitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02152358 - PTH - Preemptive Treatment for Herpesviridae | Biotech Hunter | Biotech Hunter